Benchmark Lowers Agilon Health (NYSE:AGL) Price Target to $1.50

Key Points

• Agilon Health's price target was cut from $4.00 to $1.50 by Benchmark analysts, while maintaining a "buy" rating on the stock.
• The company reported a $0.25 loss per share for the last quarter, missing expectations and showing a 5.9% year-over-year decline in quarterly revenue.
• Despite recent analyst downgrades, Agilon Health's stock saw a 5.8% increase in trading on Wednesday, with a current market price of $0.93.

Agilon Health (NYSE:AGL - Get Free Report) had its price objective lowered by analysts at Benchmark from $4.00 to $1.50 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a "buy" rating on the stock. Benchmark's price target would indicate a potential upside of 72.04% from the company's current price.

Several other research firms also recently commented on AGL. JMP Securities restated a "market perform" rating on shares of Agilon Health in a research report on Monday, April 28th. Evercore ISI cut their target price on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $3.25 to $5.00 in a research report on Friday, April 25th. Robert W. Baird cut their target price on Agilon Health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Finally, TD Cowen lifted their price objective on Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a research report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $4.07.

Agilon Health Stock Down 0.4%

Shares of AGL stock traded down $0.00 during mid-day trading on Wednesday, reaching $0.87. The stock had a trading volume of 30,405,277 shares, compared to its average volume of 15,618,723. The firm's 50 day simple moving average is $2.08 and its 200 day simple moving average is $3.15. Agilon Health has a one year low of $0.71 and a one year high of $6.08. The firm has a market cap of $361.33 million, a PE ratio of -1.13 and a beta of 0.14.

Agilon Health (NYSE:AGL - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.14). The company had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%. Agilon Health's quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter last year, the business earned ($0.07) EPS. Sell-side analysts forecast that Agilon Health will post -0.59 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Capital International Investors grew its stake in shares of Agilon Health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC grew its stake in shares of Agilon Health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after purchasing an additional 4,706,357 shares during the period. Nuveen LLC acquired a new stake in shares of Agilon Health during the first quarter worth $17,242,000. Algert Global LLC grew its stake in shares of Agilon Health by 1,042.7% during the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock worth $4,007,000 after purchasing an additional 1,924,157 shares during the period. Finally, CenterBook Partners LP acquired a new stake in shares of Agilon Health during the first quarter worth $8,315,000.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.